Omni Star Financial Group, Inc. Tarsus Pharmaceuticals, Inc. Put Options Transaction History
Omni Star Financial Group, Inc.
- $115 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TARS
# of Institutions
199Shares Held
44.1MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$138 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$136 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$108 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$103 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$102 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.11B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...